USA Financial Formulas’s Abiomed Inc ABMD Stock Holding History

USA Financial Formulas’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$1K	–	521
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	365
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	387
2021 Q2	$1K	Hold	4	–	–	﹤0.01%	369
2021 Q1	$1K	Hold	4	–	–	﹤0.01%	326
2020 Q4	$1K	Buy	+4	New	+$1.11K	﹤0.01%	309
2019 Q1	–	Sell	-6,305	Closed	-$2.84M	–	370
2018 Q4	$2.84M	Buy	6,305 +3,472	+123%	+$1.21M	0.71%	48
2018 Q3	$1.16M	Sell	2,833 -1,236	-30%	-$487K	0.29%	56
2018 Q2	$1.18M	Sell	4,069 -20	-0.5%	-$7.25K	0.29%	78
2018 Q1	$1.19M	Sell	4,089 -1,523	-27%	-$386K	0.29%	78
2017 Q4	$1.05M	Buy	+5,612	New	+$1.05M	0.25%	84
2015 Q4	–	Sell	-6,849	Closed	-$635K	–	132
2015 Q3	$635K	Sell	6,849 -717	-9%	-$63.2K	0.41%	39
2015 Q2	$497K	Sell	7,566 -5,012	-40%	-$333K	0.15%	117
2015 Q1	$900K	Buy	+12,578	New	+$683K	0.29%	79

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

USA Financial Formulas's ABMD Position: Q1 2022 in Review

USA Financial Formulas sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 4 shares — an estimated $1K sold.

USA Financial Formulas first reported a position in ABMD in Q1 2015 and held it in 13 quarters. The position peaked at $2.84M in Q4 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

USA Financial Formulas reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
USA Financial Formulas sold 4 Abiomed Inc shares in Q1 2022, an estimated $1K.
USA Financial Formulas first reported a position in Abiomed Inc in Q1 2015 and held it in 13 quarters.
USA Financial Formulas's Abiomed Inc position peaked at $2.84M in Q4 2018.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.